<産業資料/調査レポートの題名> 2022年6月15日

ヒト成長ホルモン(hGH)の世界市場:用途別(成長ホルモン欠乏症、プラダー・ウィリー症候群、ターナー症候群、在胎不当過小、その他)、投与経路別(静脈内、筋肉内、皮下、経口)、流通経路別(病院薬局、小売薬局、クリニック、 オンライン薬局)


◆英文タイトル:Human Growth Hormone (hGH) Market by Application (Growth Hormone Deficiency, Prader-Willi Syndrome, Turner Syndrome, Small for Gestational Age, and Others), Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Oral), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, and Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2019–2026

Chapter 1: Introduction

1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Research Methodology

1.3.1. Secondary Research
1.3.2. Primary Research
1.3.3. Analyst Tools & Models

Chapter 2: Executive Summary

2.1. Cxo Perspective

Chapter 3: Market Overview

3.1. Market Definition And Scope
3.2. Porter’S Five Forces Analysis
3.3. Top Player Positioning
3.4. Market Dynamics

3.4.1. Drivers

3.4.1.1. Increase In Usage Of Growth Hormone To Control Aging
3.4.1.2. Surge In Disorders Related To Growth Hormone Deficiency

3.4.2. Restraints

3.4.2.1. Side Effects Associated With The Treatment

3.4.3. Opportunities

3.4.3.1. Rise In Awareness Towards Usage Of Human Growth In Developing Economies

Chapter 4: Human Growth Hormone Market, By Application

4.1. Overview

4.1.1. Market Size And Forecast, By Application

4.2. Growth Hormone Deficiency

4.2.1. Key Market Trends And Opportunities
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Analysis, By Country

4.3. Prader-Willi Syndrome

4.3.1. Key Market Trends And Opportunities
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Analysis, By Country

4.4. Turner Syndrome

4.4.1. Key Market Trends And Opportunities
4.4.2. Market Size And Forecast, By Region
4.4.3. Market Analysis, By Country

4.5. Small For Gestational Age (Sga)

4.5.1. Key Market Trends And Opportunities
4.5.2. Market Size And Forecast, By Region
4.5.3. Market Analysis, By Country

4.6. Others

4.6.1. Key Market Trends And Opportunities
4.6.2. Market Size And Forecast, By Region
4.6.3. Market Analysis, By Country

Chapter 5: Human Growth Hormone Market, By Route Of Administration

5.1. Overview

5.1.1. Market Size And Forecast, By Application

5.2. Oral

5.2.1. Market Size And Forecast, By Region
5.2.2. Market Analysis, By Country

5.3. Intravenous

5.3.1. Market Size And Forecast, By Region
5.3.2. Market Analysis, By Country

5.4. Intramuscular

5.4.1. Market Size And Forecast, By Region
5.4.2. Market Analysis, By Country

5.5. Subcutaneous

5.5.1. Market Size And Forecast, By Region
5.5.2. Market Analysis, By Country

Chapter 6: Human Growth Hormone Market, Distribution Channel

6.1. Overview

6.1.1. Market Size And Forecast, Distribution Channel

6.2. Hospital Pharmacy

6.2.1. Market Size And Forecast, By Region
6.2.2. Market Analysis, By Country

6.3. Retail Pharmacy

6.3.1. Market Size And Forecast, By Region
6.3.2. Market Analysis, By Country

6.4. Online Pharmacy

6.4.1. Market Size And Forecast, By Region
6.4.2. Market Analysis, By Country

Chapter 7: Human Growth Hormone Market, By Region

7.1. Overview

7.1.1. Market Size And Forecast

7.2. North America

7.2.1. Key Market Trends And Opportunities
7.2.2. Market Size And Forecast, By Application
7.2.3. Market Size And Forecast, By Route Of Administration
7.2.4. Market Size And Forecast, Distribution Channel

7.2.4.1. U.S. Market Size And Forecast, By Application
7.2.4.2. U.S. Market Size And Forecast, By Route Of Administration
7.2.4.3. U.S. Market Size And Forecast, Distribution Channel
7.2.4.4. Canada Market Size And Forecast, By Application
7.2.4.5. Canada Market Size And Forecast, By Route Of Administration
7.2.4.6. Canada Market Size And Forecast, Distribution Channel
7.2.4.7. Mexico Market Size And Forecast, By Application
7.2.4.8. Mexico Market Size And Forecast, By Route Of Administration
7.2.4.9. Mexico Market Size And Forecast, Distribution Channel

7.3. Europe

7.3.1. Key Market Trends And Opportunities
7.3.2. Europe Market Size And Forecast, By Application
7.3.3. Europe Market Size And Forecast, By Route Of Administration
7.3.4. Europe Market Size And Forecast, Distribution Channel
7.3.5. Europe Market Size And Forecast, By Country

7.3.5.1. France Market Size And Forecast, By Application
7.3.5.2. France Market Size And Forecast, By Route Of Administration
7.3.5.3. France Market Size And Forecast, Distribution Channel
7.3.5.4. Uk Market Size And Forecast, By Application
7.3.5.5. Uk Market Size And Forecast, By Route Of Administration
7.3.5.6. Uk Market Size And Forecast, Distribution Channel
7.3.5.7. Germany Market Size And Forecast, By Application
7.3.5.8. Germany Market Size And Forecast, By Route Of Administration
7.3.5.9. Germany Market Size And Forecast, Distribution Channel
7.3.5.10. Spain Market Size And Forecast, By Application
7.3.5.11. Spain Market Size And Forecast, By Route Of Administration
7.3.5.12. Spain Market Size And Forecast, Distribution Channel
7.3.5.13. Rest Of Europe Market Size And Forecast, By Application
7.3.5.14. Rest Of Europe Market Size And Forecast, By Route Of Administration
7.3.5.15. Rest Of Europe Market Size And Forecast, Distribution Channel

7.4. Asia-Pacific

7.4.1. Key Market Trends And Opportunities
7.4.2. Asia-Pacific Market Size And Forecast, By Application
7.4.3. Asia-Pacific Market Size And Forecast, By Route Of Administration
7.4.4. Asia-Pacific Market Size And Forecast, Distribution Channel
7.4.5. Asia-Pacific Market Size And Forecast, By Country

7.4.5.1. Japan Market Size And Forecast, By Application
7.4.5.2. Japan Market Size And Forecast, By Route Of Administration
7.4.5.3. Japan Market Size And Forecast, Distribution Channel
7.4.5.4. China Market Size And Forecast, By Application
7.4.5.5. China Market Size And Forecast, By Route Of Administration
7.4.5.6. China Market Size And Forecast, Distribution Channel
7.4.5.7. India Market Size And Forecast, By Application
7.4.5.8. India Market Size And Forecast, By Route Of Administration
7.4.5.9. India Market Size And Forecast, Distribution Channel
7.4.5.10. Australia Market Size And Forecast, By Application
7.4.5.11. Australia Market Size And Forecast, By Application
7.4.5.12. Australia Market Size And Forecast, Distribution Channel
7.4.5.13. Rest Of Asia-Pacific Market Size And Forecast, By Application
7.4.5.14. Rest Of Asia-Pacific Market Size And Forecast, By Route Of Administration
7.4.5.15. Rest Of Asia-Pacific Market Size And Forecast, Distribution Channel

7.5. Lamea

7.5.1. Key Market Trends And Opportunities
7.5.2. Lamea Market Size And Forecast, By Application
7.5.3. Lamea Market Size And Forecast, By Route Of Administration
7.5.4. Lamea Market Size And Forecast, Distribution Channel
7.5.5. Lamea Market Size And Forecast, By Country

7.5.5.1. Brazil Market Size And Forecast, By Application
7.5.5.2. Brazil Market Size And Forecast, By Route Of Administration
7.5.5.3. Brazil Market Size And Forecast, Distribution Channel
7.5.5.4. Saudi Arabia Market Size And Forecast, By Application
7.5.5.5. Saudi Arabia Market Size And Forecast, By Route Of Administration
7.5.5.6. Saudi Arabia Market Size And Forecast, Distribution Channel
7.5.5.7. South Africa Market Size And Forecast, By Application
7.5.5.8. South Africa Market Size And Forecast, By Route Of Administration
7.5.5.9. South Africa Market Size And Forecast, Distribution Channel
7.5.5.11. Rest Of Lamea Market Size And Forecast, By Application
7.5.5.12. Rest Of Lamea Market Size And Forecast, By Route Of Administration
7.5.5.13. Rest Of Lamea Market Size And Forecast, Distribution Channel

Chapter 8: Company Profiles

8.1. Novo Nordisk

8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Business Performance

8.2. Merck & Co.

8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segments
8.2.4. Product Portfolio
8.2.5. Business Performance

8.3. Eli Lilly And Company.

8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Operating Business Segments
8.3.4. Product Portfolio
8.3.5. Business Performance

8.4. Pfizer Inc.

8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segments
8.4.4. Product Portfolio
8.4.5. Business Performance

8.5. Teva Pharmaceutical Industries.

8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Operating Business Segments
8.5.4. Product Portfolio
8.5.5. Business Performance

8.6. Novartis Ag

8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Operating Business Segments
8.6.4. Product Portfolio
8.6.5. Business Performance

8.7. Anhui Anke Biotechnology (Group) Co., Ltd.

8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Operating Business Segments
8.7.4. Product Portfolio

8.8. Roche

8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Operating Business Segments
8.8.4. Product Portfolio
8.8.5. Business Performance

8.9. Ipsen

8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Operating Business Segments
8.9.4. Product Portfolio
8.9.5. Business Performance

8.10. Ferring Bv

8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Product Portfolio
8.10.5. Business Performance


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark